Steven Chan
scientistMale0.0Global Dominance: 0.00%
Dr. Steven Chan is a senior scientist at the Princess Margaret Cancer Centre in Toronto, leading a five-year study funded by $2 million to investigate the potential of Ozempic and similar GLP-1 drugs in reducing the risk of acute myeloid leukemia (AML), a common blood cancer in older adults.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dr. Steven Chan is a senior scientist at the Princess Margaret Cancer Centre in Toronto.
Study to examine whether Ozempic can reduce the risk of blood cancerThe Globe and Mail·
Canada· 2026-02-26
Canada· 2026-02-26
